IAAG
IBIO icon

Innovative Asset Advisors Group’s iBio IBIO Stock Holding History

Innovative Asset Advisors Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3K Buy
+15,000
New +$26.8K 0.01% 286

Other funds holding IBIO

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $832M AUM 49.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SWA
SOA Wealth Advisors New York $595M AUM 25.98% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Innovative Asset Advisors Group's IBIO Position: Q2 2026 in Review

Innovative Asset Advisors Group opened a new position in iBio (IBIO) in Q2 2026: 15,000 shares worth $26.3K. The stake represents 0.01% of the portfolio and ranks #286 among its holdings.

12 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Innovative Asset Advisors Group held 15,000 shares of iBio worth $26.3K as of Q2 2026.
  • iBio was a new Innovative Asset Advisors Group position in Q2 2026.
  • iBio made up 0.01% of Innovative Asset Advisors Group's portfolio in Q2 2026, its #286 holding.
  • 12 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Innovative Asset Advisors Group's 13F filing for Q2 2026, filed 5 Aug 2026.